Alnylam Pharmaceuticals Statistics
Total Valuation
ALNY has a market cap or net worth of $48.88 billion. The enterprise value is $48.93 billion.
Important Dates
The next estimated earnings date is Thursday, February 12, 2026, before market open.
| Earnings Date | Feb 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ALNY has 132.11 million shares outstanding. The number of shares has increased by 4.82% in one year.
| Current Share Class | 132.11M |
| Shares Outstanding | 132.11M |
| Shares Change (YoY) | +4.82% |
| Shares Change (QoQ) | +5.14% |
| Owned by Insiders (%) | 0.31% |
| Owned by Institutions (%) | 99.83% |
| Float | 130.25M |
Valuation Ratios
The trailing PE ratio is 1,121.58 and the forward PE ratio is 50.76.
| PE Ratio | 1,121.58 |
| Forward PE | 50.76 |
| PS Ratio | 15.01 |
| Forward PS | 9.44 |
| PB Ratio | 208.46 |
| P/TBV Ratio | 208.97 |
| P/FCF Ratio | 220.80 |
| P/OCF Ratio | 183.84 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 152.41, with an EV/FCF ratio of 221.02.
| EV / Earnings | 1,123.05 |
| EV / Sales | 15.24 |
| EV / EBITDA | 152.41 |
| EV / EBIT | 184.83 |
| EV / FCF | 221.02 |
Financial Position
The company has a current ratio of 2.54, with a Debt / Equity ratio of 11.86.
| Current Ratio | 2.54 |
| Quick Ratio | 2.37 |
| Debt / Equity | 11.86 |
| Debt / EBITDA | 7.18 |
| Debt / FCF | 12.53 |
| Interest Coverage | 1.63 |
Financial Efficiency
Return on equity (ROE) is 32.73% and return on invested capital (ROIC) is 5.74%.
| Return on Equity (ROE) | 32.73% |
| Return on Assets (ROA) | 3.65% |
| Return on Invested Capital (ROIC) | 5.74% |
| Return on Capital Employed (ROCE) | 8.03% |
| Revenue Per Employee | $1.44M |
| Profits Per Employee | $19,536 |
| Employee Count | 2,230 |
| Asset Turnover | 0.71 |
| Inventory Turnover | 6.83 |
Taxes
| Income Tax | -75.51M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +55.46% in the last 52 weeks. The beta is 0.32, so ALNY's price volatility has been lower than the market average.
| Beta (5Y) | 0.32 |
| 52-Week Price Change | +55.46% |
| 50-Day Moving Average | 424.42 |
| 200-Day Moving Average | 376.22 |
| Relative Strength Index (RSI) | 32.53 |
| Average Volume (20 Days) | 1,774,184 |
Short Selling Information
The latest short interest is 5.53 million, so 4.19% of the outstanding shares have been sold short.
| Short Interest | 5.53M |
| Short Previous Month | 4.18M |
| Short % of Shares Out | 4.19% |
| Short % of Float | 4.25% |
| Short Ratio (days to cover) | 3.39 |
Income Statement
In the last 12 months, ALNY had revenue of $3.21 billion and earned $43.57 million in profits. Earnings per share was $0.33.
| Revenue | 3.21B |
| Gross Profit | 2.69B |
| Operating Income | 264.70M |
| Pretax Income | -31.94M |
| Net Income | 43.57M |
| EBITDA | 321.02M |
| EBIT | 264.70M |
| Earnings Per Share (EPS) | $0.33 |
Full Income StatementBalance Sheet
The company has $2.72 billion in cash and $2.77 billion in debt, with a net cash position of -$48.69 million or -$0.37 per share.
| Cash & Cash Equivalents | 2.72B |
| Total Debt | 2.77B |
| Net Cash | -48.69M |
| Net Cash Per Share | -$0.37 |
| Equity (Book Value) | 233.89M |
| Book Value Per Share | 1.77 |
| Working Capital | 2.40B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $265.86 million and capital expenditures -$44.50 million, giving a free cash flow of $221.36 million.
| Operating Cash Flow | 265.86M |
| Capital Expenditures | -44.50M |
| Free Cash Flow | 221.36M |
| FCF Per Share | $1.68 |
Full Cash Flow StatementMargins
Gross margin is 83.90%, with operating and profit margins of 8.25% and 1.36%.
| Gross Margin | 83.90% |
| Operating Margin | 8.25% |
| Pretax Margin | -1.00% |
| Profit Margin | 1.36% |
| EBITDA Margin | 10.00% |
| EBIT Margin | 8.25% |
| FCF Margin | 6.90% |
Dividends & Yields
ALNY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.82% |
| Shareholder Yield | -4.82% |
| Earnings Yield | 0.09% |
| FCF Yield | 0.45% |
Dividend DetailsAnalyst Forecast
The average price target for ALNY is $488.08, which is 31.93% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $488.08 |
| Price Target Difference | 31.93% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 27 |
| Revenue Growth Forecast (5Y) | 31.54% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ALNY has an Altman Z-Score of 4.46 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.46 |
| Piotroski F-Score | 5 |
